The Valley Desk

NCT06024239 · Interventional trial

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)

Overall registry status Completed

Phase 1

Conditions Bipolar Disorder (BPD), Generalized Anxiety Disorder (GAD), Healthy Volunteers

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov